Publications
122 found
Show per page
Jung, Ruedi, Zürcher, Simeon J., Schindera, Christina, Eser, Prisca, International Journal of Cancer, 152(2), 162–171. https://doi.org/10.1002/ijc.34234
, Schai, Anna, Braun, Julia, Deng, Wei Hai, Hebestreit, Helge, Neuhaus, Cornelia, Schaeff, Jonathan, Rueegg, Corina S., von der Weid, Nicolas X., & Kriemler, Susi. (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit).
Jung, Ruedi, Zürcher, Simeon J., Schindera, Christina, Eser, Prisca, International Journal of Cancer, 152(2), 162–171. https://doi.org/10.1002/ijc.34234
, Schai, Anna, Braun, Julia, Deng, Wei Hai, Hebestreit, Helge, Neuhaus, Cornelia, Schaeff, Jonathan, Rueegg, Corina S., von der Weid, Nicolas X., & Kriemler, Susi. (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit).
De Geyter, C., Matt, L., De Geyter, I., Moffat, R., & Human Reproduction Open, 2023. https://doi.org/10.1093/hropen/hoad038
(2023). In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable.
De Geyter, C., Matt, L., De Geyter, I., Moffat, R., & Human Reproduction Open, 2023. https://doi.org/10.1093/hropen/hoad038
(2023). In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable.
Ferrari, Serge, & Swiss Medical Weekly, 153. https://doi.org/10.57187/smw.2023.40075
. (2023). Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
Ferrari, Serge, & Swiss Medical Weekly, 153. https://doi.org/10.57187/smw.2023.40075
. (2023). Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
R Charlier SH, Cardiovascular Diabetology, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1
, Jick SS, R, & Becker C. (2022). Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study.
R Charlier SH, Cardiovascular Diabetology, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1
, Jick SS, R, & Becker C. (2022). Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study.
Bischof E, Schwab FD, Georgescu Margarint EL, Montavon C, Zünti I, Schollbach A, Schötzau A, Hirschmann A, Landin J, Bone Reports, 16, 101160. https://doi.org/10.1016/j.bonr.2021.101160
, Christian K, & Vetter M. (2022). Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience.
Bischof E, Schwab FD, Georgescu Margarint EL, Montavon C, Zünti I, Schollbach A, Schötzau A, Hirschmann A, Landin J, Bone Reports, 16, 101160. https://doi.org/10.1016/j.bonr.2021.101160
, Christian K, & Vetter M. (2022). Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience.
Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, & Journal of Bone and Mineral Research, 37(5), 837–847. https://doi.org/10.1002/jbmr.4517
. (2022). Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes.
Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, & Journal of Bone and Mineral Research, 37(5), 837–847. https://doi.org/10.1002/jbmr.4517
. (2022). Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes.
Jehle‐kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, Healthcare (Switzerland), 10. https://doi.org/10.3390/healthcare10020295
, Uebelhart, Brigitte, & Wiedersheim, Peter. (2022). Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.
Jehle‐kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, Healthcare (Switzerland), 10. https://doi.org/10.3390/healthcare10020295
, Uebelhart, Brigitte, & Wiedersheim, Peter. (2022). Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.
Paccou J., Tsourdi E., Bone, 154. https://doi.org/10.1016/j.bone.2021.116236
, Palermo A., Pepe J., Body J.-J., & Zillikens M.C. (2022). Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS).
Paccou J., Tsourdi E., Bone, 154. https://doi.org/10.1016/j.bone.2021.116236
, Palermo A., Pepe J., Body J.-J., & Zillikens M.C. (2022). Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS).
Potasso L, Potasso L, Refardt J., European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
, & Christ-Crain M. (2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Potasso L, Potasso L, Refardt J., European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
, & Christ-Crain M. (2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Vavanikunnel, J., Sewing, L., Triantafyllidou, M., Steighardt, A., Baumann, S., Egger, A., Grize, L., Felix, B., Kraenzlin, M., Henzen, C., & Calcif Tissue Int, 111(6), 587–596. https://doi.org/10.1007/s00223-022-01022-7
(2022). Determinants of low bone turnover in type 2 diabetes-the role of PTH.
Vavanikunnel, J., Sewing, L., Triantafyllidou, M., Steighardt, A., Baumann, S., Egger, A., Grize, L., Felix, B., Kraenzlin, M., Henzen, C., & Calcif Tissue Int, 111(6), 587–596. https://doi.org/10.1007/s00223-022-01022-7
(2022). Determinants of low bone turnover in type 2 diabetes-the role of PTH.
Charlier, Sarah, Vavanikunnel, Janina, Becker, Claudia, Jick, Susan S., Journal of Clinical Endocrinology and Metabolism, 106(2), 554–566. https://doi.org/10.1210/clinem/dgaa796
, & Meier, Christoph R. (2021). Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
Charlier, Sarah, Vavanikunnel, Janina, Becker, Claudia, Jick, Susan S., Journal of Clinical Endocrinology and Metabolism, 106(2), 554–566. https://doi.org/10.1210/clinem/dgaa796
, & Meier, Christoph R. (2021). Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
Tsourdi E, Zillikens MC, Journal of Clinical Endocrinology and Metabolism, 106(1), 264–281. https://doi.org/10.1210/clinem/dgaa756
, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, & Langdahl B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS.
Tsourdi E, Zillikens MC, Journal of Clinical Endocrinology and Metabolism, 106(1), 264–281. https://doi.org/10.1210/clinem/dgaa756
, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, & Langdahl B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS.
Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, International Journal of Cancer, 147(7), 1845–1854. https://doi.org/10.1002/ijc.32963
, Rueegg CS, von der Weid NX, & Kriemler S. (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit.
Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, International Journal of Cancer, 147(7), 1845–1854. https://doi.org/10.1002/ijc.32963
, Rueegg CS, von der Weid NX, & Kriemler S. (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit.
Ferrari S, Lippuner K, Lamy O, & Swiss Medical Weekly, 150(3940), w20352. https://doi.org/10.4414/SMW.2020.20352
. (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
Ferrari S, Lippuner K, Lamy O, & Swiss Medical Weekly, 150(3940), w20352. https://doi.org/10.4414/SMW.2020.20352
. (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
Pepe J., Body J.-J., Hadji P., McCloskey E., Journal of Clinical Endocrinology and Metabolism, 105(8), 2487–2506. https://doi.org/10.1210/clinem/dgaa306
, Obermayer-Pietsch B., Palermo A., Tsourdi E., Zillikens M.C., Langdahl B., & Ferrari S. (2020). Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
Pepe J., Body J.-J., Hadji P., McCloskey E., Journal of Clinical Endocrinology and Metabolism, 105(8), 2487–2506. https://doi.org/10.1210/clinem/dgaa306
, Obermayer-Pietsch B., Palermo A., Tsourdi E., Zillikens M.C., Langdahl B., & Ferrari S. (2020). Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
Müller F, Appelt KA, Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), 408–417. https://doi.org/10.1007/s00167-019-05598-w
, & Suhm N. (2020). Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
Müller F, Appelt KA, Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), 408–417. https://doi.org/10.1007/s00167-019-05598-w
, & Suhm N. (2020). Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, Bone, 127, 401–418. https://doi.org/10.1016/j.bone.2019.07.006
, McCloskey EV, Pepe J, & Zillikens MC. (2019). Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.
Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, Bone, 127, 401–418. https://doi.org/10.1016/j.bone.2019.07.006
, McCloskey EV, Pepe J, & Zillikens MC. (2019). Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.
Biver E, Calmy A, & Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf (Patent No. 8). 30(8), Article 8. https://doi.org/10.1007/s00198-019-05025-3
. (2019).
Biver E, Calmy A, & Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf (Patent No. 8). 30(8), Article 8. https://doi.org/10.1007/s00198-019-05025-3
. (2019).
Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, & Osteoporosis International, 30(5), 1125–1135. https://doi.org/10.1007/s00198-018-4794-0
. (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, & Osteoporosis International, 30(5), 1125–1135. https://doi.org/10.1007/s00198-018-4794-0
. (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Struja T, Jutzi R, Imahorn N, Kaeslin M, Boesiger F, Kutz A, Mundwiler E, Huber A, Kraenzlin M, Mueller B, BMC Endocrine Disorders, 19(1), 38. https://doi.org/10.1186/s12902-019-0363-6
, Bernasconi L, & Schuetz P. (2019). Comparison of Five TSH-receptor antibody assays in Graves’ disease: Results from an observational pilot study.
Struja T, Jutzi R, Imahorn N, Kaeslin M, Boesiger F, Kutz A, Mundwiler E, Huber A, Kraenzlin M, Mueller B, BMC Endocrine Disorders, 19(1), 38. https://doi.org/10.1186/s12902-019-0363-6
, Bernasconi L, & Schuetz P. (2019). Comparison of Five TSH-receptor antibody assays in Graves’ disease: Results from an observational pilot study.
Ebrahimi, Fahim, Wolffenbuttel, Carole, Blum, Claudine A., Baumgartner, Christine, Mueller, Beat, Schuetz, Philipp, European Respiratory Journal, 53(2), 10. https://doi.org/10.1183/13993003.00973-2018
, Kraenzlin, Marius, Christ-Crain, Mirjam, & Betz, Matthias Johannes. (2019). Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials.
Ebrahimi, Fahim, Wolffenbuttel, Carole, Blum, Claudine A., Baumgartner, Christine, Mueller, Beat, Schuetz, Philipp, European Respiratory Journal, 53(2), 10. https://doi.org/10.1183/13993003.00973-2018
, Kraenzlin, Marius, Christ-Crain, Mirjam, & Betz, Matthias Johannes. (2019). Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials.
Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, Mueller B, Hormone and Metabolic Research, 51(4), 256–260. https://doi.org/10.1055/a-0850-9691
, Bernasconi L, & Schuetz P. (2019). Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study.
Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, Mueller B, Hormone and Metabolic Research, 51(4), 256–260. https://doi.org/10.1055/a-0850-9691
, Bernasconi L, & Schuetz P. (2019). Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study.
Vavanikunnel, Janina, Charlier, Sarah, Becker, Claudia, Schneider, Cornelia, Jick, Susan S., Meier, Christoph R., & The Journal of Clinical Endocrinology and Metabolism, 104(5), 1645–1654. https://doi.org/10.1210/jc.2018-01879
. (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.
Vavanikunnel, Janina, Charlier, Sarah, Becker, Claudia, Schneider, Cornelia, Jick, Susan S., Meier, Christoph R., & The Journal of Clinical Endocrinology and Metabolism, 104(5), 1645–1654. https://doi.org/10.1210/jc.2018-01879
. (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.
Refardt, Julie, Farina, Patricia, Hoesli, Irene, & Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 34(10), 833–836. https://doi.org/10.1080/09513590.2018.1462314
. (2018). Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy.
Refardt, Julie, Farina, Patricia, Hoesli, Irene, & Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 34(10), 833–836. https://doi.org/10.1080/09513590.2018.1462314
. (2018). Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy.
Struja T, Eckart A, Kutz A, Huber A, Neyer P, Kraenzlin M, Mueller B, Frontiers in Endocrinology, 9, 623. https://doi.org/10.3389/fendo.2018.00623
, Bernasconi L, & Schuetz P. (2018). Metabolomics for Prediction of Relapse in Graves’ Disease: Observational Pilot Study.
Struja T, Eckart A, Kutz A, Huber A, Neyer P, Kraenzlin M, Mueller B, Frontiers in Endocrinology, 9, 623. https://doi.org/10.3389/fendo.2018.00623
, Bernasconi L, & Schuetz P. (2018). Metabolomics for Prediction of Relapse in Graves’ Disease: Observational Pilot Study.
Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, BMC cancer, 17(1), 822. https://doi.org/10.1186/s12885-017-3801-8
, Eser P, & von der Weid NX. (2017). A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].
Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, BMC cancer, 17(1), 822. https://doi.org/10.1186/s12885-017-3801-8
, Eser P, & von der Weid NX. (2017). A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].
Struja T, Kutz A, Fischli S, BMC medicine, 15(1), 174. https://doi.org/10.1186/s12916-017-0939-9
, Mueller B, Recher M, & Schuetz P. (2017). Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.
Struja T, Kutz A, Fischli S, BMC medicine, 15(1), 174. https://doi.org/10.1186/s12916-017-0939-9
, Mueller B, Recher M, & Schuetz P. (2017). Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.
Gotthardt, Frank, Huber, Christine, Thierfelder, Clara, Grize, Leticia, Kraenzlin, Marius, Scheidegger, Claude, & Journal of Bone and Mineral Metabolism, 35(1), 99–107. https://doi.org/10.1007/s00774-015-0732-9
. (2017). Bone mineral density and its determinants in men with opioid dependence.
Gotthardt, Frank, Huber, Christine, Thierfelder, Clara, Grize, Leticia, Kraenzlin, Marius, Scheidegger, Claude, & Journal of Bone and Mineral Metabolism, 35(1), 99–107. https://doi.org/10.1007/s00774-015-0732-9
. (2017). Bone mineral density and its determinants in men with opioid dependence.
Swiss medical weekly, 147, w14484. https://doi.org/10.4414/smw.2017.14484
, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, & Ferrari S. (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Swiss medical weekly, 147, w14484. https://doi.org/10.4414/smw.2017.14484
, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, & Ferrari S. (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Struja, Tristan, Kaeslin, Marina, Boesiger, Fabienne, Jutzi, Rebecca, Imahorn, Noemi, Kutz, Alexander, Bernasconi, Luca, Mundwiler, Esther, Mueller, Beat, Christ-Crain, Mirjam, Meienberg, Fabian, Ebrahimi, Fahim, Henzen, Christoph, Fischli, Stefan, Kraenzlin, Marius, European Journal of Endocrinology, 176(4), 413–419. https://doi.org/10.1530/eje-16-0986
, & Schuetz, Philipp. (2017). External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients.
Struja, Tristan, Kaeslin, Marina, Boesiger, Fabienne, Jutzi, Rebecca, Imahorn, Noemi, Kutz, Alexander, Bernasconi, Luca, Mundwiler, Esther, Mueller, Beat, Christ-Crain, Mirjam, Meienberg, Fabian, Ebrahimi, Fahim, Henzen, Christoph, Fischli, Stefan, Kraenzlin, Marius, European Journal of Endocrinology, 176(4), 413–419. https://doi.org/10.1530/eje-16-0986
, & Schuetz, Philipp. (2017). External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients.
Struja, Tristan Mirko, Kutz, Alexander, Fischli, Stefan, Swiss Medical Weekly, 147, w14476. https://doi.org/10.4414/smw.2017.14476
, Müller, Beat, & Schütz, Philipp. (2017). Personalised immunomodulating treatments for Graves’ disease: fact or fiction?
Struja, Tristan Mirko, Kutz, Alexander, Fischli, Stefan, Swiss Medical Weekly, 147, w14476. https://doi.org/10.4414/smw.2017.14476
, Müller, Beat, & Schütz, Philipp. (2017). Personalised immunomodulating treatments for Graves’ disease: fact or fiction?
Egger A, Kraenzlin ME, & Current Osteoporosis Reports, 14(6), 345–350. https://doi.org/10.1007/s11914-016-0337-9
. (2016). Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.
Egger A, Kraenzlin ME, & Current Osteoporosis Reports, 14(6), 345–350. https://doi.org/10.1007/s11914-016-0337-9
. (2016). Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.
Oranges CM, Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. (Patent No. 3). 138(3), Article 3. https://doi.org/10.1097/prs.0000000000002506
, & Schaefer DJ. (2016).
Oranges CM, Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. (Patent No. 3). 138(3), Article 3. https://doi.org/10.1097/prs.0000000000002506
, & Schaefer DJ. (2016).
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 563.
, Jick, Susan S., & Meier, Christoph R. (2016). New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study.
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 563.
, Jick, Susan S., & Meier, Christoph R. (2016). New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study.
Egger, A., Kraenzlin, M., & DIABETOLOGE, 12, 254–260. https://doi.org/10.1007/s11428-016-0098-1
(2016). Osteoporosis and type 2 diabetes.
Egger, A., Kraenzlin, M., & DIABETOLOGE, 12, 254–260. https://doi.org/10.1007/s11428-016-0098-1
(2016). Osteoporosis and type 2 diabetes.
Trombetti A, Christ E.R., Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms.
Trombetti A, Christ E.R., Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms.
Bone, 82, 93–100. https://doi.org/10.1016/j.bone.2015.04.026
, Schwartz AV, Egger A, & Lecka-Czernik B. (2016). Effects of diabetes drugs on the skeleton.
Bone, 82, 93–100. https://doi.org/10.1016/j.bone.2015.04.026
, Schwartz AV, Egger A, & Lecka-Czernik B. (2016). Effects of diabetes drugs on the skeleton.
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, Drug Safety, 39(12), 1229–1237. https://doi.org/10.1007/s40264-016-0462-5
, , Jick, Susan S., & Meier, Christoph R. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study.
Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, Drug Safety, 39(12), 1229–1237. https://doi.org/10.1007/s40264-016-0462-5
, , Jick, Susan S., & Meier, Christoph R. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study.
Spoendlin, Julia, Journal of Diabetes and Its Complications, 30(5), 903–909. https://doi.org/10.1016/j.jdiacomp.2016.02.017
, , Jick, Susan S., & Meier, Christoph R. (2016). Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study.
Spoendlin, Julia, Journal of Diabetes and Its Complications, 30(5), 903–909. https://doi.org/10.1016/j.jdiacomp.2016.02.017
, , Jick, Susan S., & Meier, Christoph R. (2016). Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study.
Suhm N, Der Unfallchirurg, 119(1), 12–17. https://doi.org/10.1007/s00113-015-0122-8
, Kraenzlin M, Kungler E, Savic B, Mueller S, Jakob M, & Rikli D. (2016). [FLS - three letters alter secondary fracture prevention].
Suhm N, Der Unfallchirurg, 119(1), 12–17. https://doi.org/10.1007/s00113-015-0122-8
, Kraenzlin M, Kungler E, Savic B, Mueller S, Jakob M, & Rikli D. (2016). [FLS - three letters alter secondary fracture prevention].
Theiler, R., Freystaetter, G., Platz, A., OSTEOLOGIE, 25, 283–286.
, & Mellinghoff, H. -U. (2016). Capture the fracture by SMS.
Theiler, R., Freystaetter, G., Platz, A., OSTEOLOGIE, 25, 283–286.
, & Mellinghoff, H. -U. (2016). Capture the fracture by SMS.
Annales d’endocrinologie, 76(2), 163–164. https://doi.org/10.1016/j.ando.2015.03.019
. (2015). Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
Annales d’endocrinologie, 76(2), 163–164. https://doi.org/10.1016/j.ando.2015.03.019
. (2015). Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
Spoendlin, Julia, Annals of Medicine, 47(6), 492–498. https://doi.org/10.3109/07853890.2015.1074272
, Jick, Susan S, & Meier, Christoph R. (2015). Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study.
Spoendlin, Julia, Annals of Medicine, 47(6), 492–498. https://doi.org/10.3109/07853890.2015.1074272
, Jick, Susan S, & Meier, Christoph R. (2015). Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study.
Swiss Medical Weekly, 144. https://doi.org/10.4414/smw.2014.13952
, Lamy, Olivier, Krieg, Marc-Antoine, Mellinghoff, Hans-Ulrich, Felder, Markus, Ferrari, Serge, & Rizzoli, Rene. (2014). The role of teriparatide in sequential and combination therapy of osteoporosis.
Swiss Medical Weekly, 144. https://doi.org/10.4414/smw.2014.13952
, Lamy, Olivier, Krieg, Marc-Antoine, Mellinghoff, Hans-Ulrich, Felder, Markus, Ferrari, Serge, & Rizzoli, Rene. (2014). The role of teriparatide in sequential and combination therapy of osteoporosis.
Stute P, Birkhäuser M, von Wolff M, & Swiss Medical Weekly, 144, w13931. https://doi.org/10.4414/smw.2014.13931
. (2014). Gynaecologists’ awareness of bone healthcare in Switzerland.
Stute P, Birkhäuser M, von Wolff M, & Swiss Medical Weekly, 144, w13931. https://doi.org/10.4414/smw.2014.13931
. (2014). Gynaecologists’ awareness of bone healthcare in Switzerland.
Kreutle, V., Blum, C., Swiss Medical Weekly, 144, w13979. https://doi.org/10.4414/smw.2014.13979
, Past, M., Muller, B., Schutz, P., & Borm, K. (2014). Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.
Kreutle, V., Blum, C., Swiss Medical Weekly, 144, w13979. https://doi.org/10.4414/smw.2014.13979
, Past, M., Muller, B., Schutz, P., & Borm, K. (2014). Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.
Osteoporosis International, 25(1), 359–366. https://doi.org/10.1007/s00198-013-2581-5
, , Kraenzlin, C, Friederich, N F, Wischer, T, Grize, L, R, & Kraenzlin, M E. (2014). Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial.
Osteoporosis International, 25(1), 359–366. https://doi.org/10.1007/s00198-013-2581-5
, , Kraenzlin, C, Friederich, N F, Wischer, T, Grize, L, R, & Kraenzlin, M E. (2014). Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial.
Nigro N, Christ-Crain M., & Therapeutische Umschau, 71(4), 229–237. https://doi.org/10.1024/0040-5930/a000506
. (2014). Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken.
Nigro N, Christ-Crain M., & Therapeutische Umschau, 71(4), 229–237. https://doi.org/10.1024/0040-5930/a000506
. (2014). Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken.
Henzen C, Kraenzlin M, & Therapeutische Umschau. Revue therapeutique, 70(8), 481–489. https://doi.org/10.1024/0040-5930/a000435
. (2013). [Laboratory investigation of endocrine function - interpretation of results and pitfalls].
Henzen C, Kraenzlin M, & Therapeutische Umschau. Revue therapeutique, 70(8), 481–489. https://doi.org/10.1024/0040-5930/a000435
. (2013). [Laboratory investigation of endocrine function - interpretation of results and pitfalls].
Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, & Clinical Drug Investigation, 33(2), 117–122. https://doi.org/10.1007/s40261-012-0041-1
. (2013). Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, & Clinical Drug Investigation, 33(2), 117–122. https://doi.org/10.1007/s40261-012-0041-1
. (2013). Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Therapeutische Umschau. Revue Therapeutique, 69(3), 145–152. https://doi.org/10.1024/0040-5930/a000267
, & Kraenzlin ME. (2012). [Osteoporosis: evaluation, diagnosis and monitoring].
Therapeutische Umschau. Revue Therapeutique, 69(3), 145–152. https://doi.org/10.1024/0040-5930/a000267
, & Kraenzlin ME. (2012). [Osteoporosis: evaluation, diagnosis and monitoring].
Bodmer, Michael, Becker, Claudia, The American Journal of Gastroenterology, 107(4), 620–626. https://doi.org/10.1038/ajg.2011.483
, , Jick, Susan S., & Meier, Christoph R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis.
Bodmer, Michael, Becker, Claudia, The American Journal of Gastroenterology, 107(4), 620–626. https://doi.org/10.1038/ajg.2011.483
, , Jick, Susan S., & Meier, Christoph R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis.
Bodmer, Michael, Becker, Claudia, Cancer Epidemiology Biomarkers & Prevention, 21(2), 280–286. https://doi.org/10.1158/1055-9965.epi-11-0992-t
, , Jick, Susan S., & Meier, Christoph R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer, Michael, Becker, Claudia, Cancer Epidemiology Biomarkers & Prevention, 21(2), 280–286. https://doi.org/10.1158/1055-9965.epi-11-0992-t
, , Jick, Susan S., & Meier, Christoph R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Therapeutic Advances in Musculoskeletal Disease, 3(5), 235–243. https://doi.org/10.1177/1759720x11410769
, & Kraenzlin ME. (2011). Antiepileptics and bone health.
Therapeutic Advances in Musculoskeletal Disease, 3(5), 235–243. https://doi.org/10.1177/1759720x11410769
, & Kraenzlin ME. (2011). Antiepileptics and bone health.
Suter-Widmer I, Kraenzlin ME, & Therapeutische Umschau. Revue Therapeutique, 68(6), 321–326. https://doi.org/10.1024/0040-5930/a000172
. (2011). [Primary hyperparathyroidism].
Suter-Widmer I, Kraenzlin ME, & Therapeutische Umschau. Revue Therapeutique, 68(6), 321–326. https://doi.org/10.1024/0040-5930/a000172
. (2011). [Primary hyperparathyroidism].
Bodmer, Michael, Becker, Claudia, Gynecologic Oncology, 123(2), 200–204. https://doi.org/10.1016/j.ygyno.2011.06.038
, , Jick, Susan S., & Meier, Christoph R. (2011). Use of metformin and the risk of ovarian cancer: a case-control analysis.
Bodmer, Michael, Becker, Claudia, Gynecologic Oncology, 123(2), 200–204. https://doi.org/10.1016/j.ygyno.2011.06.038
, , Jick, Susan S., & Meier, Christoph R. (2011). Use of metformin and the risk of ovarian cancer: a case-control analysis.
Kraenzlin, Marius E, & Nature Reviews. Endocrinology, 7(11), 647–656. https://doi.org/10.1038/nrendo.2011.108
. (2011). Parathyroid hormone analogues in the treatment of osteoporosis.
Kraenzlin, Marius E, & Nature Reviews. Endocrinology, 7(11), 647–656. https://doi.org/10.1038/nrendo.2011.108
. (2011). Parathyroid hormone analogues in the treatment of osteoporosis.
Swiss Medical Weekly, 141, w13260. https://doi.org/10.4414/smw.2011.13260
, & Kränzlin, Marius E. (2011). Calcium supplementation, osteoporosis and cardiovascular disease.
Swiss Medical Weekly, 141, w13260. https://doi.org/10.4414/smw.2011.13260
, & Kränzlin, Marius E. (2011). Calcium supplementation, osteoporosis and cardiovascular disease.
Suter-Widmer, Isabelle, Kraenzlin, Marius E, & Therapeutische Umschau, 68(6), 321–326. https://doi.org/10.1024/0040-5930/a000172
. (2011). Primärer Hyperparathyreoidismus.
Suter-Widmer, Isabelle, Kraenzlin, Marius E, & Therapeutische Umschau, 68(6), 321–326. https://doi.org/10.1024/0040-5930/a000172
. (2011). Primärer Hyperparathyreoidismus.
Bodmer, Michael, Drug Safety, 33(10), 843–852. https://doi.org/10.2165/11536780-000000000-00000
, , Kraenzlin, Marius E., & Meier, Christoph R. (2010). Proton pump inhibitors and fracture risk: true effect or residual confounding?
Bodmer, Michael, Drug Safety, 33(10), 843–852. https://doi.org/10.2165/11536780-000000000-00000
, , Kraenzlin, Marius E., & Meier, Christoph R. (2010). Proton pump inhibitors and fracture risk: true effect or residual confounding?
Bodmer, Michael, Diabetes Care, 33(6), 1304–1308. https://doi.org/10.2337/dc09-1791
, , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2010). Long-term metformin use is associated with decreased risk of breast cancer.
Bodmer, Michael, Diabetes Care, 33(6), 1304–1308. https://doi.org/10.2337/dc09-1791
, , Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2010). Long-term metformin use is associated with decreased risk of breast cancer.
Keel, Christina, Kraenzlin, Marius E., Kraenzlin, Claude A., Müller, Beat, & Journal of Bone and Mineral Metabolism, 28(1), 68–76. https://doi.org/10.1007/s00774-009-0101-7
. (2010). Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.
Keel, Christina, Kraenzlin, Marius E., Kraenzlin, Claude A., Müller, Beat, & Journal of Bone and Mineral Metabolism, 28(1), 68–76. https://doi.org/10.1007/s00774-009-0101-7
. (2010). Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.
Kraenzlin, Marius E, Graf, Christian, Knee Surgery, Sports Traumatology, Arthroscopy, 18(12), 1638–1644. https://doi.org/10.1007/s00167-010-1106-4
, Kraenzlin, Claude, & Friedrich, Niklaus F. (2010). Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Kraenzlin, Marius E, Graf, Christian, Knee Surgery, Sports Traumatology, Arthroscopy, 18(12), 1638–1644. https://doi.org/10.1007/s00167-010-1106-4
, Kraenzlin, Claude, & Friedrich, Niklaus F. (2010). Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Journal of clinical endocrinology and metabolism, 95(11), 4909–4916. https://doi.org/10.1210/jc.2010-0032
, Brauchli, Yolanda B, Jick, Susan S, Kraenzlin, Marius E, & Meier, Christoph R. (2010). Use of depot medroxyprogesterone acetate and fracture risk.
Journal of clinical endocrinology and metabolism, 95(11), 4909–4916. https://doi.org/10.1210/jc.2010-0032
, Brauchli, Yolanda B, Jick, Susan S, Kraenzlin, Marius E, & Meier, Christoph R. (2010). Use of depot medroxyprogesterone acetate and fracture risk.
Walter, Martin A., Cancer, 116(1), 31–40. https://doi.org/10.1002/cncr.24738
, Radimerski, Tanja, Iten, Fabienne, Kränzlin, Marius, Müller-Brand, Jan, de Groot, Jan Willem B., Kema, Ido P., Links, Thera P., & Müller, Beat. (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Walter, Martin A., Cancer, 116(1), 31–40. https://doi.org/10.1002/cncr.24738
, Radimerski, Tanja, Iten, Fabienne, Kränzlin, Marius, Müller-Brand, Jan, de Groot, Jan Willem B., Kema, Ido P., Links, Thera P., & Müller, Beat. (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Richert L, Trombetti A, Herrmann FR, Triponez F, Swiss Medical Weekly, 139(27-28), 400–404. https://doi.org/10.4414/smw.2009.12635
, Robert JH, & Rizzoli R. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.
Richert L, Trombetti A, Herrmann FR, Triponez F, Swiss Medical Weekly, 139(27-28), 400–404. https://doi.org/10.4414/smw.2009.12635
, Robert JH, & Rizzoli R. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.
Revue medicale suisse, 5(207), 1309–1310, 1312–1313.
, , Bodmer M, R, & Kraenzlin ME. (2009). [Thiazolidinediones and skeletal health].
Revue medicale suisse, 5(207), 1309–1310, 1312–1313.
, , Bodmer M, R, & Kraenzlin ME. (2009). [Thiazolidinediones and skeletal health].
Bodmer, Michael, Risk of fractures with glitazones : a critical review of the evidence to date]. Drug Safety, 32, Article 7. https://doi.org/10.2165/00002018-200932070-00001
, , Kraenzlin, Marius E, & Meier, Christoph R. (2009). Risk of fractures with glitazones : a critical review of the evidence to date [Review of
Bodmer, Michael, Risk of fractures with glitazones : a critical review of the evidence to date]. Drug Safety, 32, Article 7. https://doi.org/10.2165/00002018-200932070-00001
, , Kraenzlin, Marius E, & Meier, Christoph R. (2009). Risk of fractures with glitazones : a critical review of the evidence to date [Review of
De Geyter, C., Steimann, S., Müller, B., Kränzlin, M. E., & Thyroid, 19(1), 53–59. https://doi.org/10.1089/thy.2007.0355
(2009). Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls.
De Geyter, C., Steimann, S., Müller, B., Kränzlin, M. E., & Thyroid, 19(1), 53–59. https://doi.org/10.1089/thy.2007.0355
(2009). Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls.
Schweizerische Rundschau Für Medizin Praxis = Revue Suisse de Médecine PRAXIS, 98(20), 1141–1147. https://doi.org/10.1024/1661-8157.98.20.1141
. (2009). [Osteoporosis: diagnostic assessment].
Schweizerische Rundschau Für Medizin Praxis = Revue Suisse de Médecine PRAXIS, 98(20), 1141–1147. https://doi.org/10.1024/1661-8157.98.20.1141
. (2009). [Osteoporosis: diagnostic assessment].
Journal of Bone and Mineral Research : JBMR : The Official Journal of the American Society for Bone and Mineral Research, 24(3), 386–388. https://doi.org/10.1359/jbmr.090104
, Seibel, Markus J, & Kraenzlin, Marius E. (2009). Use of bone turnover markers in the real world: are we there yet?
Journal of Bone and Mineral Research : JBMR : The Official Journal of the American Society for Bone and Mineral Research, 24(3), 386–388. https://doi.org/10.1359/jbmr.090104
, Seibel, Markus J, & Kraenzlin, Marius E. (2009). Use of bone turnover markers in the real world: are we there yet?
Richert, Laura, Trombetti, Andrea, Herrmann, François R, Triponez, Frédéric, Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 139(27-28), 400–404. https://doi.org/smw-12635
, Robert, John H, & Rizzoli, René. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.
Richert, Laura, Trombetti, Andrea, Herrmann, François R, Triponez, Frédéric, Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 139(27-28), 400–404. https://doi.org/smw-12635
, Robert, John H, & Rizzoli, René. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.
Bodmer, Michael, Diabetes Care, 31(11), 2086–2091. https://doi.org/10.2337/dc08-1171
, Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2008). Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis.
Bodmer, Michael, Diabetes Care, 31(11), 2086–2091. https://doi.org/10.2337/dc08-1171
, Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2008). Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis.
Kraenzlin, Marius E., Kraenzlin, Claude A., Clinical Chemistry, 54(9), 1546–1553. https://doi.org/10.1373/clinchem.2008.105262
, Giunta, Cecilia, & Steinmann, Beat. (2008). Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases.
Kraenzlin, Marius E., Kraenzlin, Claude A., Clinical Chemistry, 54(9), 1546–1553. https://doi.org/10.1373/clinchem.2008.105262
, Giunta, Cecilia, & Steinmann, Beat. (2008). Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases.
Kränzlin, Marius E., & Ars Edici Dossier, Schweizer Zeitschrift Für Hausarztmedizin, 12, 27–31. https://www.rosenfluh.ch/media/arsmedici-dossier/2008/12/Praevention-der-Osteoporose.pdf
. (2008). Prävention der Osteoporose.
Kränzlin, Marius E., & Ars Edici Dossier, Schweizer Zeitschrift Für Hausarztmedizin, 12, 27–31. https://www.rosenfluh.ch/media/arsmedici-dossier/2008/12/Praevention-der-Osteoporose.pdf
. (2008). Prävention der Osteoporose.
Archives of Internal Medicine, 168(8), 820–825. https://doi.org/10.1001/archinte.168.8.820
, Kraenzlin, Marius E., Bodmer, Michael, Jick, Susan S., Jick, Hershel, & Meier, Christoph R. (2008). Use of thiazolidinediones and fracture risk.
Archives of Internal Medicine, 168(8), 820–825. https://doi.org/10.1001/archinte.168.8.820
, Kraenzlin, Marius E., Bodmer, Michael, Jick, Susan S., Jick, Hershel, & Meier, Christoph R. (2008). Use of thiazolidinediones and fracture risk.
Archives of Internal Medicine, 168(1), 47–54. https://doi.org/10.1001/archinternmed.2007.2
, Nguyen, Tuan V, Handelsman, David J, Schindler, Christian, Kushnir, Mark M, Rockwood, Alan L, Meikle, A Wayne, Center, Jacqueline R, Eisman, John A, & Seibel, Markus J. (2008). Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study.
Archives of Internal Medicine, 168(1), 47–54. https://doi.org/10.1001/archinternmed.2007.2
, Nguyen, Tuan V, Handelsman, David J, Schindler, Christian, Kushnir, Mark M, Rockwood, Alan L, Meikle, A Wayne, Center, Jacqueline R, Eisman, John A, & Seibel, Markus J. (2008). Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study.
Leading Opinons. Gynäkologie, 1, 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose.
Leading Opinons. Gynäkologie, 1, 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose.
Gynäkologie, 1, 13–20.
, & Kränzlin,ME. (2008). Therapieoptionen bei postmenopausaler Osteoporose.
Gynäkologie, 1, 13–20.
, & Kränzlin,ME. (2008). Therapieoptionen bei postmenopausaler Osteoporose.
Kränzlin,ME, & Ars Medici, 13(5), 581–585.
. (2008). Prävention der Osteoporose.
Kränzlin,ME, & Ars Medici, 13(5), 581–585.
. (2008). Prävention der Osteoporose.
Leading Opinons Gynäkologie, 1(4), 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose.
Leading Opinons Gynäkologie, 1(4), 14–17.
, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose.
Kraenzlin ME, & Nature clinical practice. Endocrinology & metabolism, 3(10), 686–687. https://doi.org/10.1038/ncpendmet0618
. (2007). Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
Kraenzlin ME, & Nature clinical practice. Endocrinology & metabolism, 3(10), 686–687. https://doi.org/10.1038/ncpendmet0618
. (2007). Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
Nguyen TV, BMC musculoskeletal disorders, 8, 13. https://doi.org/10.1186/1471-2474-8-13
, Center JR, Eisman JA, & Seibel MJ. (2007). Bone turnover in elderly men: relationships to change in bone mineral density.
Nguyen TV, BMC musculoskeletal disorders, 8, 13. https://doi.org/10.1186/1471-2474-8-13
, Center JR, Eisman JA, & Seibel MJ. (2007). Bone turnover in elderly men: relationships to change in bone mineral density.
Liu PY, Beilin J, Journal of Clinical Endocrinology and Metabolism, 92(9), 3599–3603. https://doi.org/10.1210/jc.2007-0862
, Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, & Handelsman DJ. (2007). Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts.
Liu PY, Beilin J, Journal of Clinical Endocrinology and Metabolism, 92(9), 3599–3603. https://doi.org/10.1210/jc.2007-0862
, Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, & Handelsman DJ. (2007). Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts.
Kraenzlin ME, & Expert opinion on biological therapy, 6(2), 167–176. https://doi.org/10.1517/14712598.6.2.167
. (2006). Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer.
Kraenzlin ME, & Expert opinion on biological therapy, 6(2), 167–176. https://doi.org/10.1517/14712598.6.2.167
. (2006). Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer.
Clinical laboratory, 52(1-2), 1–10.
, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, & Seibel MJ. (2006). Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget’s disease.
Clinical laboratory, 52(1-2), 1–10.
, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, & Seibel MJ. (2006). Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget’s disease.
Clinical endocrinology, 63(6), 603–616. https://doi.org/10.1111/j.1365-2265.2005.02333.x
, Liu PY, Handelsman DJ, & Seibel MJ. (2005). Endocrine regulation of bone turnover in men.
Clinical endocrinology, 63(6), 603–616. https://doi.org/10.1111/j.1365-2265.2005.02333.x
, Liu PY, Handelsman DJ, & Seibel MJ. (2005). Endocrine regulation of bone turnover in men.
Christ-Crain M, Morgenthaler NG, Swiss Medical Weekly, 135(37-38), 549–554. https://doi.org/10.4414/smw.2005.11119
, Müller C, Nussbaumer C, Bergmann A, Staub JJ, & Müller B. (2005). Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
Christ-Crain M, Morgenthaler NG, Swiss Medical Weekly, 135(37-38), 549–554. https://doi.org/10.4414/smw.2005.11119
, Müller C, Nussbaumer C, Bergmann A, Staub JJ, & Müller B. (2005). Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20(4), 579–587. https://doi.org/10.1359/jbmr.041207
, Nguyen TV, Center JR, Seibel MJ, & Eisman JA. (2005). Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20(4), 579–587. https://doi.org/10.1359/jbmr.041207
, Nguyen TV, Center JR, Seibel MJ, & Eisman JA. (2005). Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.
Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20(2), 227–231. https://doi.org/10.1359/jbmr.041106
, Hooper MJ, & Ralston SH. (2005). Ubiquitin-associated domain mutations of SQSTM1 in Paget’s disease of bone: evidence for a founder effect in patients of British descent.
Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20(2), 227–231. https://doi.org/10.1359/jbmr.041106
, Hooper MJ, & Ralston SH. (2005). Ubiquitin-associated domain mutations of SQSTM1 in Paget’s disease of bone: evidence for a founder effect in patients of British descent.
Christ-Crain, M., Journal of Clinical Endocrinology and Metabolism, 90(3), 1280–1286. https://doi.org/10.1210/jc.2004-0850
, Huber, P. R., Zimmerli, L., & Müller, B. (2005). Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.
Christ-Crain, M., Journal of Clinical Endocrinology and Metabolism, 90(3), 1280–1286. https://doi.org/10.1210/jc.2004-0850
, Huber, P. R., Zimmerli, L., & Müller, B. (2005). Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.
Clinical laboratory, 51(9-10), 509–515.
, Christ-Crain M, Christoffel-Courtin C, Staub JJ, & Müller B. (2005). Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test.
Clinical laboratory, 51(9-10), 509–515.
, Christ-Crain M, Christoffel-Courtin C, Staub JJ, & Müller B. (2005). Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test.
Z Allgemeinmed, 81(14), 289–302.
, & Kraenzlin,M.E. (2005). Diagnose und Therapie der postmenopausalen Osteoporose.
Z Allgemeinmed, 81(14), 289–302.
, & Kraenzlin,M.E. (2005). Diagnose und Therapie der postmenopausalen Osteoporose.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 19(8), 1221–1230. https://doi.org/10.1359/jbmr.040511
, Woitge HW, Witte K, Lemmer B, & Seibel MJ. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 19(8), 1221–1230. https://doi.org/10.1359/jbmr.040511
, Woitge HW, Witte K, Lemmer B, & Seibel MJ. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Journal of Clinical Endocrinology and Metabolism, 89(6), 3033–3041. https://doi.org/10.1210/jc.2003-031992
, Liu PY, Ly LP, de Winter-Modzelewski J, Jimenez M, Handelsman DJ, & Seibel MJ. (2004). Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
Journal of Clinical Endocrinology and Metabolism, 89(6), 3033–3041. https://doi.org/10.1210/jc.2003-031992
, Liu PY, Ly LP, de Winter-Modzelewski J, Jimenez M, Handelsman DJ, & Seibel MJ. (2004). Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
Christ-Crain M, Swiss Medical Weekly, 134(13-14), 193–197. https://doi.org/10.4414/smw.2004.10559
, Huber P, Zimmerli L, Trummler M, & Müller B. (2004). Comparison of different methods for the measurement of serum testosterone in the aging male.
Christ-Crain M, Swiss Medical Weekly, 134(13-14), 193–197. https://doi.org/10.4414/smw.2004.10559
, Huber P, Zimmerli L, Trummler M, & Müller B. (2004). Comparison of different methods for the measurement of serum testosterone in the aging male.
Christ-Crain, M., Müller, B., Gasser, T. C., Kraenzlin, M., Trummler, M., Huber, P., & Journal of Urology, 172(2), 624–627. https://doi.org/10.1097/01.ju.0000135303.96496.ee
(2004). Is there a clinical relevance of partial androgen deficiency of the aging male?
Christ-Crain, M., Müller, B., Gasser, T. C., Kraenzlin, M., Trummler, M., Huber, P., & Journal of Urology, 172(2), 624–627. https://doi.org/10.1097/01.ju.0000135303.96496.ee
(2004). Is there a clinical relevance of partial androgen deficiency of the aging male?
Established therapeutic options in postmenopausal osteoporosis (Patent No. 2). 11(2), Article 2. https://api.elsevier.com/content/abstract/scopus_id/3042735031
, & Kränzlin,ME. (2004).
Established therapeutic options in postmenopausal osteoporosis (Patent No. 2). 11(2), Article 2. https://api.elsevier.com/content/abstract/scopus_id/3042735031
, & Kränzlin,ME. (2004).
Osteoporosis International, 15(3), 209–216. https://doi.org/10.1007/s00198-003-1527-8
, Muller, B., Guglielmetti, M., Christ-Crain, M., Staub, J. J., & Kraenzlin, M. (2004). Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.
Osteoporosis International, 15(3), 209–216. https://doi.org/10.1007/s00198-003-1527-8
, Muller, B., Guglielmetti, M., Christ-Crain, M., Staub, J. J., & Kraenzlin, M. (2004). Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.
Seibel MJ, Seasonal variation of bone turnover? (Patent No. 1). 19(1), Article 1. https://doi.org/10.1359/jbmr.0301218
, Woitge H, Witte K, & Lemmer B. (2004).
Seibel MJ, Seasonal variation of bone turnover? (Patent No. 1). 19(1), Article 1. https://doi.org/10.1359/jbmr.0301218
, Woitge H, Witte K, & Lemmer B. (2004).